Literature DB >> 18162108

Estimating cumulative treatment effects in the presence of nonproportional hazards.

Guanghui Wei1, Douglas E Schaubel1.   

Abstract

Often in medical studies of time to an event, the treatment effect is not constant over time. In the context of Cox regression modeling, the most frequent solution is to apply a model that assumes the treatment effect is either piecewise constant or varies smoothly over time, i.e., the Cox nonproportional hazards model. This approach has at least two major limitations. First, it is generally difficult to assess whether the parametric form chosen for the treatment effect is correct. Second, in the presence of nonproportional hazards, investigators are usually more interested in the cumulative than the instantaneous treatment effect (e.g., determining if and when the survival functions cross). Therefore, we propose an estimator for the aggregate treatment effect in the presence of nonproportional hazards. Our estimator is based on the treatment-specific baseline cumulative hazards estimated under a stratified Cox model. No functional form for the nonproportionality need be assumed. Asymptotic properties of the proposed estimators are derived, and the finite-sample properties are assessed in simulation studies. Pointwise and simultaneous confidence bands of the estimator can be computed. The proposed method is applied to data from a national organ failure registry.

Entities:  

Mesh:

Year:  2007        PMID: 18162108     DOI: 10.1111/j.1541-0420.2007.00947.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  12 in total

1.  Confidence bands for the difference between two median survival times as a function of covariates.

Authors:  Yuh-Ing Chen; Yu-Mei Chang; Jen-Yu Lee
Journal:  Lifetime Data Anal       Date:  2013-10-05       Impact factor: 1.588

2.  Flexible modeling of the hazard rate and treatment effects in long-term survival studies.

Authors:  Yolanda Hagar; James J Dignam; Vanja Dukic
Journal:  Stat Methods Med Res       Date:  2017-02-02       Impact factor: 3.021

3.  Simultaneous confidence bands for Cox regression from semiparametric random censorship.

Authors:  Shoubhik Mondal; Sundarraman Subramanian
Journal:  Lifetime Data Anal       Date:  2015-02-18       Impact factor: 1.588

4.  A propensity-matched comparison of hard outcomes in children on chronic dialysis.

Authors:  Enrico Vidal; Nicholas C Chesnaye; Fabio Paglialonga; Bruno Minale; Giovanna Leozappa; Mario Giordano; Bruno Gianoglio; Ciro Corrado; Rosa Maria Roperto; Roberto Chimenz; Francesca Mencarelli; Ilse-Maria Ratsch; Luisa Murer; Enrico Verrina
Journal:  Eur J Pediatr       Date:  2017-11-16       Impact factor: 3.183

5.  Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.

Authors:  Douglas E Schaubel; Guanghui Wei
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

6.  Cumulative Hazard Ratio Estimation for Treatment Regimes in Sequentially Randomized Clinical Trials.

Authors:  Xinyu Tang; Abdus S Wahed
Journal:  Stat Biosci       Date:  2015-05

7.  A proposal for an additional clinical trial outcome measure assessing preventive effect as delay of events.

Authors:  Per Lytsy; Lars Berglund; Johan Sundström
Journal:  Eur J Epidemiol       Date:  2012-12-07       Impact factor: 8.082

8.  Semiparametric Contrasts of Cumulative Pre-Treatment Mortality in the Presence of Dependent Censoring.

Authors:  Qi Gong; Douglas E Schaubel
Journal:  Stat Biosci       Date:  2014-07-02

9.  Restricted mean survival time as a function of restriction time.

Authors:  Yingchao Zhong; Douglas E Schaubel
Journal:  Biometrics       Date:  2020-12-17       Impact factor: 2.571

10.  A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation.

Authors:  Randall S Sung; Min Zhang; Douglas E Schaubel; Xu Shu; John C Magee
Journal:  Transplantation       Date:  2015-09       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.